We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Adalimumab successful in sarcoidosis patients with refractory chronic non-infectious uveitis.
- Authors
Erckens, R J; Mostard, R L M; Wijnen, P A H M; Schouten, J S; Drent, M
- Abstract
Adalimumab, a humanized monoclonal antibody targeted against TNF-α, has proved to be successful in the treatment of uveitis. Another anti-TNF-α agent, i.e., infliximab, has been reported of benefit in the treatment of refractory sarcoidosis. The aim of this prospective case series was to evaluate the effect of adalimumab on intraocular inflammatory signs and other relevant clinical manifestations (lung function, serological inflammatory parameters, and fatigue) of sarcoidosis.
- Publication
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2012, Vol 250, Issue 5, p713
- ISSN
1435-702X
- Publication type
Journal Article
- DOI
10.1007/s00417-011-1844-0